2022
Human biodistribution and radiation dosimetry of the demyelination tracer [18F]3F4AP
Brugarolas P, Wilks M, Noel J, Kaiser J, Vesper D, Ramos-Torres K, Guehl N, Macdonald-Soccorso M, Sun Y, Rice P, Yokell D, Lim R, Normandin M, El Fakhri G. Human biodistribution and radiation dosimetry of the demyelination tracer [18F]3F4AP. European Journal Of Nuclear Medicine And Molecular Imaging 2022, 50: 344-351. PMID: 36197499, PMCID: PMC9816249, DOI: 10.1007/s00259-022-05980-w.Peer-Reviewed Original ResearchConceptsRadiation dosimetryTime-activity curvesAdverse eventsEffective doseMultiple bed positionsComprehensive metabolic panelNonhuman primatesHealthy human volunteersNo adverse eventsDynamic PET scansVoltage-gated potassiumAnimal models of neurological diseasesNonhuman primate studiesModels of neurological diseasesHuman biodistributionAverage effective doseMetabolic panelDosimetryOLINDA softwareHealthy volunteersUrinary bladderPET scansDemyelinating lesionsBed positionAnimal models
2009
Improved MAGIC gel for higher sensitivity and elemental tissue equivalent 3D dosimetry
Zhu X, Reese T, Crowley E, Fakhri G. Improved MAGIC gel for higher sensitivity and elemental tissue equivalent 3D dosimetry. Medical Physics 2009, 37: 183-188. PMID: 20175480, PMCID: PMC2801736, DOI: 10.1118/1.3260844.Peer-Reviewed Original ResearchConceptsMAGIC gelTissue equivalentsGel dosimeterRange verificationNuclear reactionsDosimetry applicationsProton beam therapyPhantom materialTime-activity measurementsDosimetry purposesTransverse relaxation rateRelaxation rateBeam therapyDose-response curveSlopes of dose-response curvesGel formulationMAGICDose responseMelting pointSoft tissueDosimetersPhantomTime-activityProtonGlucose